baber/WOPTO huggingface dataset:
Patent JP-2000508662-A (JP)
Title: 抗新生物薬および抗レトロウイルス薬として有用なアクリドンから誘導された化合物
IPC: A61K31/00
Filed: 1997-04-09
Abstract: (57)【要約】
本発明は、アクリドンから誘導された式（Ｉ）または（ＩＩ）の幾つかの新規な化合物に関する。これらの化合物は有効な抗ウイルス薬であり、ヒト免疫不全ウイルスなどのウイルス性疾患の処置に有用である。さらにこれらの化合物は、種々の形態の癌の処置に有用な抗新生物薬である。これらの式（Ｉ）または（ＩＩ）において、Ｒ 1 およびＲ 2 は独立して−Ｈ、−ＯＨ、アミノ、アルキルアミノ、ジアルキルアミノ、アルコキシ、アルキル、ハロアルキルまたはハロゲンであり；ｎは２〜６であり；ＸおよびＸ’は独立して−Ｎまたは−ＮＯ 2 であり；ＹおよびＹ’は独立して−Ｎまたは−ＣＨまたは−Ｈであり；二重破線は二重結合または結合なしを表す。
Patent JP-2001505443-A (JP)
Title: 光力学治療のためのバルーンカテーテル
IPC: A61B17/00
Filed: 1997-05-16
Abstract: (57)【要約】
本発明は、処置領域への均一な光の送達を必要とする治療において用いられる、改良されたバルーンカテーテル装置を提供する。改良された装置は、規定された処置ウィンドウを有するバルーンを含み、ウィンドウの輪郭は反射材料を用いて規定される。装置はさらに、拡散チップ内で終了する光ファイバケーブルを含み得、拡散チップは処置ウィンドウよりも長い。本発明はさらに、本発明の改良されたバルーンカテーテルを用いる改良された治療方法を提供する。
Patent JP-2000512094-A (JP)
IPC: H04L69/14
Filed: 1997-05-28
Abstract: The present invention is a method and apparatus for transmitting a high rate data packet in a CDMA communication system. The transmission system transmits a first channel assignment message indicating the at least one additional channel that will be used to support the high rate data packet. The first channel assignment message is sent in advance of the onset of high rate data communications. In addition the present invention provides within the first frame of high rate data a duplicate channel assignment message. A remote receiver uses the channel assignment messages to initialize its demodulation elements to receive the additional information carried on the at least one additional channel.
Patent JP-2001503341-A (JP)
IPC: B29C55/28
Filed: 1997-05-29
Abstract: PCT No. PCT/US97/09377 Sec. 371 Date Nov. 12, 1998 Sec. 102(e) Date Nov. 12, 1998 PCT Filed May 29, 1997 PCT Pub. No. WO97/45247 PCT Pub. Date Dec. 4, 1997An apparatus and process for expanding polymeric tubing including a bubble of trapped gas within the polymeric tubing. The tubing is expanded by creating a pressure differential between the inside and outside of the tubing such that the pressure inside the tubing is greater than the pressure outside the tubing, thereby causing the tubing to expand. It is possible with the present invention to compensate for loss of gas pressure, thereby increasing the amount of tubing which can be expanded without ceasing production and restarting the process.
Patent MD-20020231-A (MD)
Title: Aerodynamic wind-driven plant
Inventor: BOLOGA MIRCEA
IPC: F24S90/00
Filed: 2002-09-12
Abstract: The invention relates to the power engineering, in particular to devices using the wind and the sun power, converting it into mechanical and electric one. The plant may be used for obtaining sweet water. The plant includes a solar heater (1) with transparent cover, containing two sectors: a thermo-insulating sector (2) and a humidity condensation one (3), an air duct with air intake (4) and a turbo-generator (5). The air duct is made in the form of a semi-cylinder, containing two sectors: one horizontal and another inclined, and it is placed onto the soil surface (6), having the form of a semi-cylinder of smaller radius, the ratio of the air duct's length towards the width of its base being of at least 10. Claims: 1Fig.: 2<IMAGE>
Patent MX-152345-A (MX)
Inventor: IVANOV KONSTANTIN
IPC: A61B17/06
Filed: 1983-02-16
Abstract: A retainer for surgical sutures comprising three panels which provide for a separate needle compartment and a separate suture compartment. The panels are aligned so that once the needle has been placed in position, the winding of a suture maintains the needle in the desired position.
Patent NZ-204615-A (NZ)
Title: Pellet for introducing substance into ruminant animal
Inventor: HEMINGWAY R G
IPC: A61M31/00
Filed: 1983-06-16
Abstract: The device comprises a core (1) containing nutrient and/or therapeutic material and an insoluble rigid skin (2) enclosing the core (1). The skin (2) is thin and brittle and requires the support of the core to maintain its integrity.For use, prior to introduction of the device in an animal's digestive tract a portion of the skin is removed (3A or 3B and possibly 3C or 3D) (if one end of the core had not been left exposed during manufacture) exposing a portion or portions of the core (1). As the exposed portion dissolves within the animal support is locally removed from the skin (2), the unsupported portion of the skin then disintegrating so that no hindrance is placed in the way of further dissolution of the core.
Patent NZ-219682-A (NZ)
Title: Extruding smooth-bore pipes with external ribs
Inventor: JARVENKYLA J
IPC: B29C48/13
Filed: 1987-03-18
Abstract: This invention relates to a method and an apparatus for the production of ribbed pipes. The apparatus comprises a core (8, 9, 10) which together with an extrusion sleeve (4) forms a nozzle (11) through which a plastic material is fed into a moulding space (12) defined between a mandrel (9) and chill moulds (1, 2) moveable with respect to the mandrel. Ribbed pipes produced by means of known apparatuses have, for various reasons, an uneven inner face, incomplete ribs or air closures and weak seams in the pipe walls and ribs. These disadvantages can be eliminated by such a dimensioning of the moulding space (12) of the apparatus and the grooves (13) of the chill moulds that the volume of a space defined between a plane (20) extending adjacent to the end face of the extrusion sleeve, a surface (16) of the mandrel, and a plane (17) comprising the envelope surface of the kernel (10) equals to the combined volume of the grooves (13) positioned within the area of the mandrel at each particular moment.
Patent NZ-224616-A (NZ)
Title: Container made from paperboard/polyethylene laminate
Inventor: GIBBONS CHARLES E
IPC: B32B27/28
Filed: 1988-05-13
Abstract: The present invention relates to a non-foil composite barrier for an improved container for citrus juices and other liquids. The container utilizes a paperboard barrier laminate for the containment of essential oils and the prevention of losses of vitamin C. Also disclosed is a process of making the laminate. The laminate makes use of an inner barrier layer of a heat-sealable ethylene vinyl alcohol copolymer to enhance the barrier properties of the laminate. The invention provides a container for liquids containing essential oils and/or flavors constructed from a laminated characterized by the fact that it comprises:     a) a paperboard substrate (36); b) a thin outer layer (34) of a heat sealable low density polyethylene polymer coated on said outer surface of said paperboard substrate;   c) an ethylene vinyl alcohol copolymer layer (44); and   d) a heat sealable layer of a low density polyethylene layer (46).
Patent NZ-224664-A (NZ)
Title: Display panel
Inventor: BANNISTER BRIAN CHARLES
IPC: G09F1/12
Filed: 1988-05-17
Abstract: A display structure is disclosed comprising rectangular panels each having at its upper edge a cross member (7) providing an upwardly open channel (80) which receives a central formation (68) of a retaining member (54) which provides, at its upper end, on opposite sides, respective downwardly open channels (60). In a lowered position of the retaining member, the outer wall (62) of each channel (60) extends on the outer side of the member (7) and can serve to retain the upper edge of a respective display card fitted in the panel. The releasing member can be raised, then tilted, whilst being held captive on the member (7) by an enlarged lower end part (76, 78) of the central formation which cannot pass between flanges (82) on member (7), to a position to one side of the respective side face of member (7) to allow vertical insertion or removal of the display card or the like. The central formation (68) may also provide an upwardly open channel (72) to receive a downwardly extending tongue on a similar panel, whereby similar panels may be fitted one on top of the other. The panels may have catch members (20, 100) for engagement in cut-outs (112) in such tongues to hold together panels thus fitted one on top of the other.
Patent NZ-225942-A (NZ)
Title: Expandible window shade formed from folded and pleated sheet material
Inventor: NEFF CRAIG A
IPC: B31D3/02
Filed: 1988-08-26
Abstract: An expandable collapsible product is made by providing a pleated sheet (8,10) having legs (20) which are made by securing two parts of a fold (17) together. Two sheets are combined by securing the end of a leg (20) to a crease (16) or a leg (20) of an opposite sheet. The sheet material can be folded to provide alternating taller folds (17) and shorter folds (16), and the taller folds are modified to provide the legs (20) by glueing parts of the taller folds (17) together. Glueing can be accomplished by moving glue heads across the sheet at high velocity through the use of linear motors. The glue lines may be heated after being laid down by the use of electro-magnetic radiation, preferably from a high-powered laser. The finished product may be used as insulated window coverings, or the like.
Patent NZ-235193-A (NZ)
Title: Quinone derivatives, preparation and pharmaceutical compositions thereof
Inventor: ABE SHINYA
IPC: C07D265/30
Filed: 1990-09-06
Abstract: The quinone compound is useful to treat hepatic disease and defined by the formula: <CHEM>  wherein A is a group represented by the formula: <CHEM> (wherein R<3>, R<4> and R<5> which may be the same or different from each other are each a hydrogen atom, a lower alkyl group or a lower alkoxy group) or a group represented by the formula: <CHEM> (wherein R<3>, R<4> and R<5> which may be the same or different from each other are each a hydrogen atom, a lower alkyl group or a lower alkoxy group, X and Y which may be the same or different from each other are each a hydroxyl group, a group represented by the formula &lparstr& OCH2 &rparstr& @ OR<6> (wherein n is 0 or 1 and R<6> is a lower alkyl group), or an acyl group), R<1> is an alkyl group having 2 to 20 carbon atoms, a cycloalkyl group, a cycloalkylalkyl group, an alkenyl group, an alkynyl group, an arylalkyl group, a group represented by the formula  &lparstr& CH2 &rparstr& @ CN (wherein p is an integer of 1 to 10), a heteroarylalkyl group, a group represented by the formula  &lparstr& CH2 &rparstr& @ B {wherein q is an integer of 1 to 6 and B is a group represented by the formula: <CHEM> (wherein r is 0 or an integer of 1 to 2, R<7> is a lower alkyl group, a cycloalkyl group or an aryl group), or a group represented by the formula -O-R<8> (wherein R<8> is a lower alkyl group or an aryl group)}, or a group represented by the formula  &lparstr& CH2-CH2-O)@ CH3 (wherein s is an integer of 1 to 3), R<2> is a group represented by the formula -OR<8> (wherein R<8> is a hydrogen atom or a lower alkyl group) or a group represented by the formula: <CHEM> (wherein R<9> and R<1><0> which may be the same of different from each other are each a hydrogen atom, a lower alkyl group, a hydroxyalkyl group or a heteroaryl group, provided that R<9> and R<1><0> may be combined with each other to form a ring together with a nitrogen atom bonded thereto, which may further contain a nitrogen atom and/or an oxygen atom and may be substituted).
Patent NZ-235581-A (NZ)
Title: Controlled release plaster comprising a pressure-sensitive acrylic/methacrylic acid polymer adhesive with active substances dissolved therein
Inventor: HOFFMANN HANS-RAINER
IPC: A61M37/00
Filed: 1990-10-05
Abstract: The invention relates to a drug plaster for the controlled delivery of drugs to the skin, which consists of a backing layer and of a water-insoluble adhesive film which is attached thereto and is composed of an adhesive which contains polymers which are swellable in water and in which the drug is at least partially soluble, and of a protective layer which covers the adhesive film and can be detached again, which is characterised in that the adhesive is based on homo- and/or copolymers with at least one derivative of acrylic or methacrylic acid and contains, as drugs partially or completely dissolved in the adhesive, in a concentration of 0.5 to 10.0% by weight, oestrogens and their pharmaceutically acceptable derivatives alone or in combination with gestagens.
Patent NZ-250363-A (NZ)
Title: A topical dressing containing a dessicant and an antimicrobial or antiseptic agent
Inventor: CHALMERS SUSANNA ELIZABETH
IPC: A61L15/44
Filed: 1993-12-06
Abstract: This invention relates to a pharmaceutical composition for use in treating an abnormal skin condition, such as a wound, a burn or a blister, in an animal or human. The pharmaceutical composition has an antiseptic or antimicrobial agent and a desiccant for adsorbing moisture or liquid, in and around the area of the abnormal skin, in a form such that the adsorbed moisture or liquid is not readily available to the skin.
Patent NZ-271214-A (NZ)
Title: Current collector cell cap with electrolyte seal
Inventor: GEORGOPOULOS PHILIP
IPC: H01M50/179
Filed: 1994-08-03
Abstract: An electrochemical cell including a current collector assembly having a current collector, a seal and a compression means wherein the compression means and collector exert minimum tension and maximum compressive stresses on the seal thereby avoiding leakage of electrolyte either through or around the seal.
Patent NZ-284851-A (NZ)
Title: 1-[3-(piperazin-1-yl)-prop-1-yl] benzimidazole derivatives and their use in the treatment of cns disorders
Inventor: FARACI WILLIAM S
IPC: A61P27/14
Filed: 1995-05-18
Abstract: This invention relates to novel, pharmaceutically active benzimidazole derivatives of formula (I), wherein the dotted line, X and R<1> through R<7>, R<11> and R<15> through R<17> are defined as in the specification. These compounds exhibit central dopaminergic activity and are useful in the treatment of CNS disorders.
Patent NZ-330865-A (NZ)
Title: Low static conditioning shampoo
Inventor: PATEL AMRIT M
IPC: C11D3/20
Filed: 1997-01-13
Abstract: he application provides an effective conditioning shampoo composition which is free of conditioning amounts of silicone conditioning agents. It comprises: A)	about 5 % to about 40 % of a detersive surfactant mixture of an anionic detergent and an amphoteric surfactant, the weight ratio of the anionic detergent to the amphoteric surfactant being in the range of about 10:1 to 0.8:1; B)	about 0.05 % to about 6 % of a conditioning agent selected from the group consisting of 0.05 % to 5 % of a complex of essentially equimolar amounts of a C8-C18 (EtO)1-10 carboxylic acid, and a C8C18 alkyl (EtO)0-10 dimethyl amine; 0.05 % to 1.0 % of a polyquaternary compound selected from the group consisting of a quaternized cellulosic polymer and a mixture of the quaternized cellulosic polymer with a non-cellulosic quaternary conditioning polymer; and mixtures of the foregoing; C)	0.1 % to 1 % of a static control mixture of a quaternary ammonium salt having the formula R9, R10, R11, R12 N+X- wherein R9 is a C14-C18 alkyl, R10 and R11 are each a C1-C4 alkyl, R12 is C1-C4 alkyl or benzyl and X- is a salt forming cation selected from the group consisting of chloride, bromide, methosulfate and ethosulfate; and a diquaternary ammonium salt having the formula (R13)2R14R15N+X- wherein R13 is a C14-C18 alkyl or alkylene group and R14 and R15 are each a C1-C4 alkyl group or a (CH2CH20)nH group with at least one of R14 and R15 being a (CH2CH20)nH group, n is an integer from 2 to 20 and X is a cation as set forth above, the weight ratio of the monoalkyl quaternary salt to dialkyl quaternary salt being from about 1:4 to 4:1; and D)	an aqueous medium. These compositions exhibit enhanced antistatic properties as compared to the same compositions containing either the monoalkyl quaternary salt or the dialkyl quaternary salt as the sole antistatic ingredient.
Patent NZ-332140-A (NZ)
Title: Portable container for storing filming equipment on location, has an outside flap
Inventor: O'BRIEN PHILIPPA EULALIE
IPC: G03B17/16
Filed: 1999-10-07
Abstract: A container 1 which is flexible comprises a floor portion 2, a wall portion 3 extending from and around floor portion 2 and a roof portion 4.  At least part of roof portion 4 is capable of opening to allow access to an area within the container.  A flap portion 6 is joined to the rest of container 1 and can be moved to a position adjacent floor portion 2 and wall portion 3 so that a person can kneel on flap portion 6 outside container 1 while accessing the area within container 1.
Patent NZ-333151-A (NZ)
Title: Stable liquid crystal detergent compositions
Inventor: MASSAUX JEAN
IPC: C11D1/72
Filed: 1997-06-11
Abstract: This specification describes a liquid crystal composition comprising: (a)  0.1 to 20% of a nonionic surfactant containing ethylene oxide groups, (b) 1 to 20% of a sodium salt of a C8-C16 alkyl benzene sulphonate surfactant, (c) 0.1 to 10% of an amorphous silica having a particle size of about 8 to 300 microns, (d) 0 to 15% of tripropylene glycol n-butyl ether, (e) 0.02 to 15% of a water insoluble organic compound selected from the group consisting of perfumes, essential oils and water insoluble hydrocarbons, (f) 0.5 to 10% of an alkali metal carbonate, (g) 0.1 to 4% of an unsaturated fatty acid having 12 to 20 carbons, and the balance being (h) water. The liquid crystal surfactant has a pH of 10 to 13 and does not contain sulfate surfactant or polyphosphates.
Patent NZ-335284-A (NZ)
Title: Fluid delivery device with fluid delivered from reservoir to upper portion typically by capillary action and typically used as insect bait station
Inventor: WOODRUFF KEITH FLOYD
IPC: A01M1/20
Filed: 1999-04-19
Abstract: The station (typically a bait station) consists of a reservoir 10 located between top surface 6 and bottom surface 8.  Fluid is able to move from reservoir 10 to one or more predetermined openings 18.  Typically fluid movement is by capillary action via tubes 38 and insects can access the space between surface 6 and cover 28 via ramps 12.
Patent NZ-336063-A (NZ)
Title: Ocular scleral prosthesis for treatment of presbyopia and other eye disorders
Inventor: SCHACHAR RONALD A
IPC: A61F2/14
Filed: 1998-05-21
Abstract: Presbyopia is treated by implanting within a plurality of elongated pockets (120) formed in the tissue of the sclera (102) of the eye transverse to a meridian of the eye, a prosthesis (200) having an elongated base member having an inward surface adapted to be placed against the inward wall (126) of the pocket (120) and having a ridge (214) on the inward surface of the base extending along at least a major portion of the major dimension of the base. The combined effect of the implanted prostheses is to exert a radially outward traction on the sclera in the region overlying the ciliary body (116) which expands the sclera in the affected region together with the underlying ciliary body. The expansion of the ciliary body restores the effective working distance of the ciliary muscle in the presbyopic eye and thereby increases the amplitude of accommodation. Hyperopia, primary open angle glaucoma and/or ocular hypertension can be treated by increasing the effective working distance of the ciliary muscle by inserting this prosthesis.
Patent NZ-337325-A (NZ)
Title: Tetrahydropyrido compounds and use for treating gastrointestinal disease
Inventor: SENN-BILFINGER JORG
IPC: C07D471/14
Filed: 1998-03-19
Abstract: Compounds of formula I may be used for the prevention and treatment of gastrointestinal diseases, particularly peptic ulcer disorders. In formula I; R1 is C1-4 alkyl; R2 is C1-4alkyl or hydroxy-C1-4 alkyl; R3 is hydrogen or halogen; one of the substituents R4a and R4b is hydrogen and the other is hydrogen, hydroxyl, C1-4 alkoxy, C1-4-alkoxy-C1-4alkoxy or C1-4-alkylcarbonyloxy; or in which R4a and R4b together are oxygen; one of the substituents R5a and R5b is hydrogen and the other is hydrogen, hydroxyl, C1-4 alkoxy, C1-4-alkoxy-C1-4alkoxy or C1-4-alkylcarbonyloxy; or in which R5a and R5b together are oxygen; or in which one of the substituents R4a and R4b on the one hand and one of the substituents R5a and R5b on the other hand is in each case hydrogen, and the other substituents in each case together form a methylenedioxy radical (-O-CH2-O-) or an ethylenedioxy radical (O-CH2-CH2-O); where R4a, R4b, R5a and R5b are not simultaneously hydrogen; R6 is hydrogen, halogen, C1-4alkyl, C1-4alkoxy, C1-4alkoxycarbonylamino, C1-4alkoxy-C1-4-alkoxycarbonylamino or trifluoromethyl; and R7 is hydrogen, halogen, C1-4 alkyl or C1-4 alkoxy.
Patent NZ-338034-A (NZ)
Title: Stable glycerin iodine concentrate compositions
Inventor: FORET CHRIS
IPC: A01N59/12
Filed: 1998-03-13
Abstract: Stable aqueous glycerin iodine concentrates are provided which are adapted for dilution in water to yield germicidal iodine use solutions. The concentrates include from about 30-87 % by weight glycerin, from about 0.15-15 % by weight iodine, from about 0.15-15 % by weight iodide ion, and one or more additives such as compatible wetting agents, hydrotropes, thickening agents, additional emollients and buffering systems. The concentrates are stable for a period of at least about 3 months at room temperature and are dilutable at a ratio of 1 part concentrate with from about 2-80 parts water. The concentrates can be formulated to give very low free iodine values as concentrates, but provide dramatically increased free iodine values as diluted use solutions.
Patent NZ-500294-A (NZ)
Title: Continuous crystallization system with controlled nucleation for milk fat fractionation
Inventor: YUPING SHI
IPC: A23C15/14
Filed: 1998-05-07
Abstract: An apparatus for fractionating a melt of mixed triglycerides, the apparatus comprising: i) a heat exchanger for super cooling the mass of mixed triglycerides; ii) a nucleator for controlling the energy and condition of the melt of mixed triglycerides, the nucleator having an inlet and an outlet and including an agitator means, the inlet of the nucleator being connected to the heat exchanger; and iii) a crystalliser connected to the outlet of the nucleator; where the heat exchanger is capable of providing the Gibbs free energy threshold for nucleation. Also described is a method of fractionating a mass of triglycerides, the method comprising the steps of: i) heating the mixed mass of triglycerides to form a melt; ii) cooling the melt to a temperature below the temperature sufficient for crystal growth and above the critical temperature of the melt to form a supercooled solution; iii) inputting energy to the super cooled solution sufficient to form crystal nuclei; and iv) growing the crystal nuclei into crystals in a static solution.